Volume 82 | ESPE2014 | Next issue

ESPE 2014

Dublin, Ireland
18 Sep 2014 - 20 Sep 2014

Card image cap
Dublin, Ireland; 18-20 September 2014. Further information

Poster Category 3

Diabetes (1)

hrp0082p3-d2-712 | Diabetes (1) | ESPE2014

Audit of the Use of Integrated Care Pathway in the Management of Diabetic Keto Acidosis in Children

Palakurthi Ravi , Weerasinghe Kamal

Background: Diabetic keto acidosis is a complex metabolic state of hyperglycaemia, ketosis, and acidosis. Integrated care pathway for the management of DKA was introduced in 2007. At our hospital we use potassium infusion prepared by pharmacy that allows us to alter the rate of infusion for variable potassium delivery.Objective and hypotheses: To check the adherence to integrated care pathway. To identify whether alteration of the rate of potassium infus...

hrp0082p3-d2-713 | Diabetes (1) | ESPE2014

Development of Diabetes Mellitus after Hematopoietic Stem Cell Transplantation for Childhood Leukemia

Jung In Ah , Jun Yeon Jin , Cho Won Kyoung , Lee Jae Wook , Chung Nak Gyun , Jung Min Ho , Cho Bin , Suh Byung Kyu

Background: Hematopoietic stem cell transplantation (HSCT) recipients are at risk of endocrine complications as a result of chemotherapy and radiation therapy. Development of diabetes mellitus (DM) after HSCT is less frequently reported compared with other complications.Objective and hypotheses: We investigated clinical features of newly diagnosed DM after HSCT for treatment of childhood leukemia.Method: Between April 1999 and Marc...

hrp0082p3-d2-714 | Diabetes (1) | ESPE2014

Case of Family Neonatal Diabetes with KCNJ11 Gene Mutation

Chumak Svitlana , Budreiko Olena , Globa Evgeniy

Background: Neonatal diabetes is a rare pathology occurring in around one in every 200 000–400 000 live births. The most common cause of permanent neonatal diabetes (PNDM) is heterozygous activating mutations in the KCNJ11 gene encoding the pore-forming Kir6.2 subunit of the pancreatic β cell KATP channel.Objective and hypotheses: To determine the dynamic of carbohydrate metabolism in family transferred from insulin to sulphonylureas (...

hrp0082p3-d2-715 | Diabetes (1) | ESPE2014

Insulin Pump Therapy in One Case of 6q24 Transient Neonatal Diabetes for 3 Years

Wangkai Liu , Xiaoyu Li , Yihua Su , Siqi Zhuang , Yijuan Li , Huamei Ma , Minlian Du , Weiqi Chen

Background: Management of transient neonatal diabetes mellitus is complex. Conventional insulin therapy may be increase additional medical problems. From the case is presented, We suggested s.c. insulin pump therapy of neonatal diabetes is a safe and effective approach to management.Objective and hypotheses: To evaluate the therapeutic effect of continuous s.c. insulin infusion with insulin pump in a case with transient neonatal diabetes mellitus (TNDM)....

hrp0082p3-d2-716 | Diabetes (1) | ESPE2014

Uptake of a Novel Tool to Adjust Insulin Boluses, Based on CGM Trend Arrows and Insulin Sensitivity (Trend Arrow Adjustment Tool); in Children with Type 1 Diabetes, Who are Using Insulin Pump Therapy and Continuous Glucose Monitoring

Heffernan Emmeline , Lawson Margaret

Background: Real-time CGM data includes ‘trend arrows’ which indicate when the blood glucose is rapidly falling or rising thus enabling the pump user to make immediate adjustments in insulin delivery to prevent subsequent low or high blood sugars. However, effective strategies for adjusting insulin boluses based on CGM trend arrows are lacking. Previous studies recommended that boluses be adjusted based on trend arrows using a standard 10–20% increase/decrease o...

hrp0082p3-d2-717 | Diabetes (1) | ESPE2014

Diabetes Mellitus a Late Complication in Glycogen Storage Disease Type 1b

Kumar Kiran , Sachdev Pooja , Randell Tabitha , Denvir Louise

Background: Diabetes mellitus is a late complication in glycogen storage disease type 1 (GSD1). Patients with GSD1 who are poorly controlled have prolonged periods of low glucose levels. As they grow older they become tolerant to these hypoglycaemic episodes, and may be mildly symptomatic or asymptomatic even with low glucose levels. This results in adaptive mechanisms, mediated through down regulation of glucose receptor on the β-cell membrane (GLUT2) to reduce insulin s...

hrp0082p3-d2-718 | Diabetes (1) | ESPE2014

Incidence of Diabetes Mellitus and Associated Complications Among Children: Results from Azerbaijan Diabetes Registry 1997–2007

Ahmadov Gunduz

Background: Diabetes prevalence is increasing globally, and Azerbaijan is no exception. Poorly controlled diabetes is associated with increased long-term micro-vascular and macro-vascular complication risk, leading to an increased morbidity and mortality.Objective and hypotheses: The purpose of this study was to estimate incidence of diabetes mellitus (DM) among children aged 0–18 years and to assess growth, glycaemic control, complications, risk fa...

hrp0082p3-d2-719 | Diabetes (1) | ESPE2014

Arabic Translation and Validation of the Newest Vital Sign Health Literacy Tool: a Pilot Project to Test Health Literacy of Caregivers of Children with Type 1 Diabetes in Kuwait

Al-Abdulrazzaq Dalia , Al-Haddad Muneera , AbdulRasoul Majedah , Al-Basari Iman , Al-Taiar Abdulla

Introduction: Health literacy is a recognized concept in diabetes care. The newest vital sign (NVS) is an English instrument established to test health literacy using a nutrition label. No studies looked into health literacy in the Arab world. Our aim is to translate and validate the NVS tool to Arabic then test it on a pilot of Arabic-speaking caregivers of children with type 1 diabetes.Methods: i) Production of the Arabic version: the English version o...

hrp0082p3-d2-720 | Diabetes (1) | ESPE2014

Anti-Cyclic Citrullinated Peptide Antibodies are not Frequent in Children with Type 1 Diabetes

Yildiz Melek , Isleten Figen , Demir Korcan , Celik Nilufer , Korkmaz Huseyin Anil , Tuglu Birsen , Elmas Ozlem Nalbantoglu , Ozkan Behzat

Background: Type 1 diabetes mellitus is characterized by presence of several organ specific autoantibodies. Anti-cyclic citrullinated peptide (anti-CCP) antibody is a promising marker of rheumatoid arthritis (RA) which is known to coincide with autoimmune diabetes. Presence of these antibodies was not investigated in children with type 1 diabetes.Objective and hypotheses: To evaluate presence of anti-CCP antibodies in children with type 1 diabetes compar...

hrp0082p3-d2-721 | Diabetes (1) | ESPE2014

Glycemic Variability and Metabolic Control in Pediatric Patients with Type 1 Diabetes Mellitus

Martin-Frias Maria , Roldan M Belen , Alonso M Milagros , Oyakawa Yoko Patricia , Alonso Daniel , Barrio Raquel

Introduction: Recently, the impact of glycemic variability in the development of chronic complications of diabetes has been put in question. The gold-standard method to quantify glycemic variability is not well established.Objective: To analyze the relationship between HbA1c and glycemic variability as determined from self-monitoring blood glucose (SMBG) in type 1 diabetes (T1D) pediatric population.Patients/methods: Cross-sectiona...

hrp0082p3-d2-722 | Diabetes (1) | ESPE2014

Knowledge Base and Attitudes of Senior Medical Staff to Insulin Therapy in Children with Diabetes

Nuti Amith , Bidder Christopher , Phillips Geraldine , Vamadevan Puvaneswary , Fraser Carol

Background: Knowledge on multiple daily injections (MDI) and continuous subcutaneous insulin infusion (CSII) regimen impacts on the out-of-hours advice given to families of children with diabetes. As such, knowledge base and attitudes of senior medical staff particularly middle grades regarding insulin therapy is paramount.Objective: Assessing confidence levels of middle grade doctors to provide advice on insulin regimens. We conducted a questionnaire ba...

hrp0082p3-d2-723 | Diabetes (1) | ESPE2014

Estimation of Compensation and Prevalence of Chronic Complications of Type 1 DM in Children According to the Screening Data

Alimova Nasiba , Rakhimova Gulnara

Objective and hypotheses: The work was initiated to comparatively assess degree of compensation and prevalence of complications of type 1 DM in children in Uzbekistan from 1998 to 2012 according to the screening data.Method: 950 children (coverage of 80.3%) with type 1 DM were screened in 2012 within the WDF grant ‘Children’s Diabetes in Uzbekistan’, the degree of compensation and prevalence of type 1 DM chronic complications were compared...